We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Defends Neulasta Manufacturing Patent in Biosimilar Suit Against Coherus
Amgen Defends Neulasta Manufacturing Patent in Biosimilar Suit Against Coherus
Amgen is suing Coherus Biosciences over its processes for manufacturing a biosimilar of Neulasta, saying it infringes patented methods for purifying proteins.